- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2011
- Public Summary Document (PSD) March 2011 PBAC Meeting - PDF
Dabigatran etexilate – March 2011
Dabigatran etexilate, capsules, 110 mg and 150 mg (as mesilate), Pradaxa® - March 2011
Last updated
1 July 2011